Champions Oncology, Inc. (CSBR)Healthcare | Biotechnology | Hackensack, United States | NasdaqCM
5.80 USD
-0.27
(-4.525%) ⇩
(April 21, 2026, 2:51 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★★☆☆☆ |
Hot Take | April 19, 2026, 12:19 a.m. EDT
Heavy defensive positioning at lower strikes via options (high IV, high OI on April 2.5 puts) contrasts with negligible near-term call activity, creating a technical ceiling around the current $6 level; fundamentally, the stock is on life support with negative revenue growth, a deeply negative ROE, and no dividend safety net, making it a low-conviction hold until clinical data clarifies the path to profitability. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.140088 |
| AutoARIMA | 0.140549 |
| MSTL | 0.149590 |
| AutoTheta | 0.150052 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 3.17 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 0.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 114.185 |
| Revenue per Share | 4.199 |
| Market Cap | 80,544,976 |
| Forward P/E | 58.00 |
| Beta | 0.40 |
| Profit Margins | -4.04% |
| Website | https://www.championsoncology.com |
As of April 19, 2026, 12:19 a.m. EDT: Contrasting signals dominate the options flow. Short-dated (April 17) calls show extremely low participation (1 vol/2 OI) against near-zero premium, while the volatility surface for these calls is high (23.66 IV) despite the lack of speculative volume. Conversely, April puts show heavy positioning with 10 volume contracts and 232 OI at the 2.5 strike, backed by significantly higher implied volatility (35.94 IV), indicating strong buyer protection or hedging at lower levels. Further out (May/August), the disparity persists: Calls show heavier interest than Puts, yet Puts generally have higher IV in near-term strikes, suggesting a defensive stance near current price while speculating upside requires lower volatility assumption.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.22646308 |
| Address1 | One University Plaza |
| Address2 | Suite 307 |
| All Time High | 25.8 |
| All Time Low | 1.11 |
| Ask | 6.27 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 6,940 |
| Average Daily Volume3 Month | 7,514 |
| Average Volume | 7,514 |
| Average Volume10Days | 6,940 |
| Beta | 0.404 |
| Bid | 6.15 |
| Bid Size | 1 |
| Book Value | 0.308 |
| City | Hackensack |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.8001 |
| Current Ratio | 0.976 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.01 |
| Day Low | 5.8001 |
| Debt To Equity | 114.185 |
| Display Name | Champions Oncology |
| Earnings Call Timestamp End | 1,773,347,400 |
| Earnings Call Timestamp Start | 1,773,347,400 |
| Earnings Timestamp | 1,773,345,600 |
| Earnings Timestamp End | 1,773,345,600 |
| Earnings Timestamp Start | 1,773,345,600 |
| Ebitda | -772,000 |
| Ebitda Margins | -0.01332 |
| Enterprise To Ebitda | -106.644 |
| Enterprise To Revenue | 1.421 |
| Enterprise Value | 82,329,464 |
| Eps Forward | 0.1 |
| Eps Trailing Twelve Months | -0.18 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.9538 |
| Fifty Day Average Change | -0.15370035 |
| Fifty Day Average Change Percent | -0.025815504 |
| Fifty Two Week Change Percent | -22.646309 |
| Fifty Two Week High | 9.63 |
| Fifty Two Week High Change | -3.8299003 |
| Fifty Two Week High Change Percent | -0.3977051 |
| Fifty Two Week Low | 5.5 |
| Fifty Two Week Low Change | 0.30009985 |
| Fifty Two Week Low Change Percent | 0.054563608 |
| Fifty Two Week Range | 5.5 - 9.63 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,170,426,600,000 |
| Float Shares | 5,188,396 |
| Forward Eps | 0.1 |
| Forward P E | 58.001 |
| Free Cashflow | 4,702,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 213 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.45878 |
| Gross Profits | 26,584,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.26672 |
| Held Percent Institutions | 0.48104998 |
| Implied Shares Outstanding | 13,886,826 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,745,971,200 |
| Last Split Date | 1,439,337,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. |
| Long Name | Champions Oncology, Inc. |
| Market | us_market |
| Market Cap | 80,544,976 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_323655 |
| Most Recent Quarter | 1,769,817,600 |
| Net Income To Common | -2,343,000 |
| Next Fiscal Year End | 1,777,507,200 |
| Non Diluted Market Cap | 84,362,467 |
| Open | 5.93 |
| Operating Cashflow | 4,394,000 |
| Operating Margins | -0.01129 |
| Payout Ratio | 0.0 |
| Phone | 201 808 8400 |
| Previous Close | 6.075 |
| Price Hint | 2 |
| Price To Book | 18.831493 |
| Price To Sales Trailing12 Months | 1.3900247 |
| Profit Margins | -0.040430002 |
| Quick Ratio | 0.928 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.27489996 |
| Regular Market Change Percent | -4.525102 |
| Regular Market Day High | 6.01 |
| Regular Market Day Low | 5.8001 |
| Regular Market Day Range | 5.8001 - 6.01 |
| Regular Market Open | 5.93 |
| Regular Market Previous Close | 6.075 |
| Regular Market Price | 5.8001 |
| Regular Market Time | 1,776,797,504 |
| Regular Market Volume | 12,869 |
| Return On Assets | -0.047020003 |
| Return On Equity | -0.47588003 |
| Revenue Growth | -0.028 |
| Revenue Per Share | 4.199 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 13,886,826 |
| Shares Percent Shares Out | 0.0058999998 |
| Shares Short | 81,893 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 69,629 |
| Short Name | Champions Oncology, Inc. |
| Short Percent Of Float | 0.012 |
| Short Ratio | 8.73 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CSBR |
| Total Cash | 7,127,000 |
| Total Cash Per Share | 0.513 |
| Total Debt | 4,999,000 |
| Total Revenue | 57,945,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.18 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.6367 |
| Two Hundred Day Average Change | -0.8366003 |
| Two Hundred Day Average Change Percent | -0.12605667 |
| Type Disp | Equity |
| Volume | 12,869 |
| Website | https://www.championsoncology.com |
| Zip | 7,601 |